Institutional investors purchased a net $4.1 million shares of IMMU during the quarter ended September 2013, and now own 42.83% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
S.A.C. CAPITAL ADVISORS LP Bought 1.8 Million shares of Immunomedics Inc
SIGMA CAPITAL MANAGEMENT LLC Bought 1.4 Million shares of Immunomedics Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.0 Million shares of Immunomedics Inc